Výsledky vyhledávání - "Bosomprah Samuel"

Akademický článek

Measurement of the plasma levels of antibodies against the polymorphic vaccine candidate apical membrane antigen 1 in a malaria-exposed population

Autor: Kusi Kwadwo A, Dodoo Daniel, Bosomprah Samuel, van der Eijk Marjolein, Faber Bart W, Kocken Clemens HM, Remarque Edmond J

Publikováno v: BMC Infectious Diseases, Vol 12, Iss 1, p 32 (2012)

Abstract Background Establishing antibody correlates of protection against malaria in human field studies and clinical trials requires, amongst others, an accurate estimation of antibody levels. For polymorphic antigens such as apical membrane antige

Externí odkaz: https://doaj.org/article/3a77bca7a090467cb09a2e1c8dd71e24

Zobrazit plný text záznamu

Akademický článek

Antibody levels to multiple malaria vaccine candidate antigens in relation to clinical malaria episodes in children in the Kasena-Nankana district of Northern Ghana

Autor: Oduro Abraham R, Egyir Beverly, Lamptey Helena, Ansah Patrick, Ansah Nana, Bosomprah Samuel, Atuguba Frank, Dodoo Daniel, Gyan Ben, Hodgson Abraham, Koram Kwadwo A

Publikováno v: Malaria Journal, Vol 10, Iss 1, p 108 (2011)

Abstract Background Considering the natural history of malaria of continued susceptibility to infection and episodes of illness that decline in frequency and severity over time, studies which attempt to relate immune response to protection must be lo

Externí odkaz: https://doaj.org/article/65c484a745d84bc1955ccc15cb9f132f

Zobrazit plný text záznamu

Akademický článek

Satisfactory safety and immunogenicity of MSP3 malaria vaccine candidate in Tanzanian children aged 12–24 months

Autor: Segeja Method D, Minja Daniel, Rutta Acleus, Sembuche Samwel, Seth Misago, Lemnge Martha, Francis Filbert, Msham Salum, Gesase Samwel, Lusingu John PA, Bosomprah Samuel, Cousens Simon, Noor Ramadhani, Chilengi Roma, Druilhe Pierre

Publikováno v: Malaria Journal, Vol 8, Iss 1, p 163 (2009)

Abstract Background Development and deployment of an effective malaria vaccine would complement existing malaria control measures. A blood stage malaria vaccine candidate, Merozoite Surface Protein-3 (MSP3), produced as a long synthetic peptide, has

Externí odkaz: https://doaj.org/article/2b11ac9b0d22418fb7125a749df2a7b8

Zobrazit plný text záznamu

Akademický článek

Safety, tolerability, and immunogenicity of an oral inactivated ETEC vaccine (ETVAX®) with dmLT adjuvant in healthy adults and children in Zambia: An age descending randomised, placebo-controlled trial

Autor: Sukwa, Nsofwa, Mubanga, Cynthia, Hatyoka, Luiza M., Chilyabanyama, Obvious N., Chibuye, Mwelwa, Mundia, Samson, Munyinda, Masiliso, Kamuti, Ethel, Siyambango, Muyunda, Badiozzaman, Sharif, Bosomprah, Samuel, Carlin, Nils, Kaim, Joanna, Sjöstrand, Björn, Simuyandi, Michelo, Chilengi, Roma, Svennerholm, Ann-Mari

Publikováno v: In Vaccine 2 November 2023 41(46):6884-6894

Zobrazit plný text záznamu

Akademický článek

Cohort study of the association of antibody levels to AMA1, MSP119, MSP3 and GLURP with protection from clinical malaria in Ghanaian children

Autor: Bosomprah Samuel, Milligan Paul, Remarque Ed, Lamptey Helena, Kusi Kwadwo, Aikins Anastasia, Dodoo Daniel, Chilengi Roma, Osei Yaa Difie, Akanmori Bartholomew, Theisen Michael

Publikováno v: Malaria Journal, Vol 7, Iss 1, p 142 (2008)

Abstract Background Antigen-specific antibody-mediated immune responses play an important role in natural protection against clinical malaria, but conflicting estimates of this association have emerged from immuno-epidemiological studies in different

Externí odkaz: https://doaj.org/article/f39180b187694fc6b5c25412beea41e4

Zobrazit plný text záznamu